Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001140361-18-026543

10% owner bought 69,444 shares at $18.00 ($1,249,992)

  • 10% owner acquired 830,999 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Cormorant Asset Management, LP · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-29 Conversion : show line 1 in the form +830,999 830,999 I
2018-05-29 Purchase : show line 2 in the form +69,444 $18.00 $1,249,992 900,443 I
Open-market purchases · 69,444 sh · avg $18.00 · $1,249,992

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-29 Conversion : show line 3 in the form Series C Preferred Shares −830,999 0 D
Loading xslF345X03/doc1.xml…